Gerresheimer stock | 2026 price target, earnings & valuation

Gerresheimer

XTRA:GXI

€ 20,48

€-0,28 (-1,35%)

20,48 €

€-0,28 (-1,35%)

End-of-day quote: 03/27/2026

Gerresheimer Stock Value

Currently, analysts rate XTRA:GXI as Hold.

Hold

Gerresheimer Company Info

EPS Growth 5Y

3,76%

Market Cap

€0,71 B

Long-Term Debt

€0,87 B

Annual earnings

N/A

Dividend

€0,04

Dividend Yield

0,19%

Founded

1864

Industry

Health Care

Country

Germany

Website

Gerresheimer

ISIN Number

DE000A0LD6E6

Website

http://www.gerresheimer.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€22,00

7.42%

Last Update: 03/28/2026

Analysts: 11

Highest Price Target €46,00

Average Price Target €22,00

Lowest Price Target €12,50

In the last five quarters, Gerresheimer’s Price Target has fallen from €546,06 to €101,24 - a -81,46% decrease. Ten analysts predict that Gerresheimer’s share price will increase in the coming year, reaching €22,00. This would represent an increase of 7,42%.

Top growth stocks in the health care sector (5Y.)

What does Gerresheimer do?

Gerresheimer AG is a leading global partner to the pharma and healthcare industries, specializing in the development and manufacture of primary packaging and drug delivery systems. The company provides a wide array of products and services that facilitate the taking and administration of medicinal drugs through innovative containment solutions, such as glass and plastic containers, as well as specialized delivery systems. In a rapidly evolving market where demands for safety, convenience, and ef...

Business Segments

The company operates through several key business segments, primarily Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. Each segment is designed to cater to distinct needs within the pharmaceutical and healthcare sectors, thus maximizing operational efficiency and fostering innovation.

Plastics & Devices Segment

This segment focuses on the design and manufacture of a broad range of sophisticated plastic solutions, including injection-molded containers, closures, and delivery systems. The segment caters to the growing demand for user-friendly and disposable drug delivery devices. The company's investments in advanced manufacturing technologies ensure the production of high-quality products that meet stringent regulatory requirements.

Primary Packaging Glass Segment

This segment specializes in glass containers, providing various shapes and sizes for the storage and administration of pharmaceuticals. The company's glass products are renowned for their safety and reliability, ensuring that medications remain uncontaminated and effective. The company emphasizes sustainable manufacturing processes, incorporating environmentally friendly practices into its glass production.

Advanced Technologies Segment

This segment encompasses innovations that integrate modern technology into traditional pharmaceutical packaging and delivery. This includes digital solutions that enhance user experience and improve medication adherence. By focusing on cutting-edge research and development, this segment positions the company as a forward-thinking leader in medical technology.

Business Strategy

The company's business strategy is centered around achieving profitable, sustainable growth while driving innovation across its product lines. The company prioritizes investments in research and development, aiming to create state-of-the-art packaging solutions that not only satisfy current market demands but also anticipate future trends.

The company adopts a customer-centric approach that revolves around fostering deep relationships with clients, based on exemplary quality and reliability. This strategy leads to enhanced customer loyalty and repeat business, which are crucial for sustaining revenue growth. To achieve these objectives, the company leverages its robust manufacturing capabilities and comprehensive industry knowledge.

The company has also committed to a sustainable business model that incorporates environmental considerations into product design and production processes. By focusing on sustainability, the company aligns with global trends towards eco-friendliness and responsible manufacturing, positioning itself as an ethical choice in the eyes of consumers and stakeholders alike.

Products and Services

The company offers a diverse range of products and services tailored to the healthcare and pharmaceutical industries. The primary offerings include,

Primary Packaging

The company produces a wide array of containers designed for storing and administering medications, including vials, ampoules, and pre-filled syringes in both glass and plastic materials.

Drug Delivery Systems

The company's innovative delivery systems include insulin pens, inhalers, and other devices that enhance the ease of medication administration.

Custom Solutions

The company collaborates closely with clients to develop customized solutions tailored to meet specific regulatory compliance and product requirements.

Consulting and Regulatory Support

The company provides expert consulting services to assist clients in navigating the complex regulatory landscape associated with pharmaceutical packaging.

Sustainability Initiatives

The company is also dedicated to improving the sustainability of its packaging solutions by integrating recycled materials and employing energy-efficient processes within its manufacturing plants.

Geographical Markets Served

The company operates on a global scale, with a significant presence in Europe, North America, and Asia. The company's strategic locations enable it to effectively serve a diverse customer base, ensuring that clients across varying markets can access the company's high-quality products and services. Furthermore, the company is continuously exploring opportunities to expand into emerging markets, where the demand for advanced healthcare solutions is rapidly increasing.

Recent Acquisitions

The company completed the acquisition of the remaining shares in Gerresheimer respimetrix GmbH, located in Düsseldorf. This acquisition signifies the company's commitment to expanding its capabilities and consolidating its position in the market for innovative drug delivery solutions.

Seasonality

The company's operations are influenced by seasonality, primarily stemming from the pharmaceutical industry's cyclical demand patterns. However, because the company serves a broad range of clients across various sectors, the overall impact of seasonality is moderated. The continuous need for pharmaceutical products creates a degree of stability, allowing the company to maintain consistent operational performance throughout the year.

Customers

The company serves a diverse customer base that includes leading pharmaceutical companies, biotech firms, and healthcare providers. The company has established long-term partnerships with numerous global organizations, ensuring both supply reliability and quality assurance. By engaging with a wide range of customers, the company tailor its products and services to meet specific industry needs.

Modes of Sales and Marketing/Distribution Channels

The company employs a multi-faceted approach to sales and marketing. The company utilizes direct sales teams, digital marketing strategies, and strategic partnerships to operate with clients effectively. The distribution channels are designed to ensure that products reach customers promptly and efficiently. Through maintaining strong relationships with suppliers and logistics partners, the company is able to guarantee fast service and reliability, which are paramount in the pharmaceutical industry.

History

Gerresheimer AG was founded in 1864.

Gerresheimer Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Industry Revenues:** - Pharma & Healthcare: approx. 60% - Cosmetics: approx. 25% - Food & Beverages: approx. 15% **TOP 3 Markets:** - Germany: approx. 30% - USA: approx. 25% - China: approx. 20% Gerresheimer AG generates the majority of its revenues in the Pharma & Healthcare sector,...

At which locations are the company’s products manufactured?

**Production Sites:** - Europe - North America - South America - Asia Gerresheimer AG is a leading provider of specialty products made of glass and plastic for the pharmaceutical, healthcare, and cosmetics industries. The company operates production facilities in multiple regions worldwide to effic...

What strategy does Gerresheimer pursue for future growth?

**Strategy for Future Growth:** Gerresheimer AG pursues a strategy focused on innovation, sustainability, and geographical expansion. The company plans to expand its product range through investments in research and development to offer innovative solutions in the field of specialty packaging and...

Which raw materials are imported and from which countries?

**Main raw materials:** Glass, plastic, aluminum **Countries of origin:** Germany, USA, China, India Gerresheimer AG is a leading manufacturer of specialty glass and plastic products. The main raw materials imported by the company are glass, plastic, and aluminum. These materials are essential fo...

How strong is the company’s competitive advantage?

**Market share:** 20% in the field of pharmaceutical primary packaging (2025, estimate) **EBITDA margin:** 22% (2025) **Research & Development:** 5% of revenue (2025) Gerresheimer AG has a significant competitive advantage due to its strong market position in the field of pharmaceutical prima...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 60% (2026, estimated) **Insider Purchases/Sales:** No significant changes in the last year (2026, estimated) The institutional investor share at Gerresheimer AG typically stands at around 60%, indicating the trust of large investors in the company&#0...

What percentage market share does Gerresheimer have?

**Market share of Gerresheimer AG:** 12% (estimated, 2026) **Top competitors and their market shares:** 1. **Schott AG:** 15% 2. **Amcor plc:** 14% 3. **Berry Global Group, Inc.:** 13% 4. **Gerresheimer AG:** 12% 5. **Stölzle Glass Group:** 10% 6. **Ardagh Group S.A.:** 9% 7. **Owens-Illinois, Inc....

Is Gerresheimer stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **EBITDA Margin:** 21% (2025) **Free Cash Flow:** 150 million euros (2025) Gerresheimer AG recorded solid revenue growth of 8.5% in 2025, attributed to increased demand for their pharmaceutical packaging solutions and medical technology products. The EBITDA margin of...

Does Gerresheimer pay a dividend – and how reliable is the payout?

**Dividend Yield:** 1.8% (2026, estimated) **Dividend History:** Continuous payout over the last 5 years Gerresheimer AG has been paying out a consistent dividend in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2026 is around 1.8%, which can be considered...

New support ticket

Explore

Gerresheimer Stock Value

Gerresheimer Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Gerresheimer do?

Gerresheimer Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Gerresheimer Stock Value

Gerresheimer Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Gerresheimer do?

Gerresheimer Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.